Classifications | Chinese medicines | Models | Mechanisms | References |
---|---|---|---|---|
Heat-clearing and dampness-drying medicine | Casticin | RAW264.7 | Repress the NF-κBp65 nucleus translocation | [44] |
Baicalin | DSS-induced colon tissue | Reduce the protein levels of NF-κBp65 and p-NF-κBp65 | [45] | |
UC patients | Decrease ratios of p-NF-κB/NF-κB | [46] | ||
Wogonin | Caco-2 cells | Decrease NF-κB activity | [47] | |
Wogonoside | DSS-induced colon tissues | Inhibit nuclear translocation of NF-κBp65, phosphorylated p65 and NF-κB DNA binding activity | [48] | |
AOM/DSS-induced tumor tissues | Inhibit the protein expression of p-p65 | [49] | ||
THP-1 cells | Suppress NF-κB nuclear translocation | [49] | ||
Berberine | Colonic macrophages and epithelial cells | Inhibit activation of NF-κB | [50] | |
(±)-8-ADC | DSS-induced colon tissues | Reduce phosphor-NF-κBp65 expression; Decrease the NF-κB mRNA expression | [53] | |
IEC6 Cells | Reduce phosphor-NF-κBp65 expression | [53] | ||
Berberine hydrochloride | DSS-induced colonic tissues | Suppress the expressions of phosphorylation of NF-κBp65 | ||
Apocynin | DSS-induced tissues | Reduce the activation of NF-κBp65 | [56] | |
Matrine | TNBS-induced colonic mucosa | Reduce the overexpression of NF-κBp65 | [58] | |
Oxymatrine | TNBS-induced colon mucosa | Down-regulate the expression of NF-κBp65 | [59] | |
Ampelopsis grossedentata | DSS-induced colon tissues | Suppress the NF-κB activation | [60] | |
SM934 | DSS-induced colon tissue | Decrease phosphorylation of NF-κB | [61] | |
Macrophages | Suppress phosphorylation of NF-κBp65; Inhibit NF-κB nuclear translocation | [61] | ||
Artesunate | RAW264.7 cells | Reduce the expression levels of p‑NF‑κB | [62] | |
Tetrandrine | DSS-induced colon tissue | Inhibit the binding activity of NF-κB to DNA | [63] | |
Polygonum cuspidatum Siebold & Zucc. | DSS-induced colon tissue | Suppress the NF-κB | [64] | |
Interior-warming and drying dampness medicine | Aesculin | RAW264.7 cells | Inhibit p-NF‑κBp65 levels in nucleus | [65] |
Total triterpenoids of Chaenomeles speciosa | DSS-induced colon tissue | Down-regulate the protein expressions of nucleus NF-κBp65, up-regulate the protein expressions of cytosol NF-κBp65 | [66] | |
Cardamonin | RAW264.7 cells | Prevent the nuclear accumulation of NF‑κBp65; Block the translocation of NF‑κBp65 | [67] | |
AA-induced colon tissue | Reduce the levels of NF-κB | [69] | ||
3,4-Oxo-isopropylidene-shikimic acid | TNBS-induced colon tissues | Decrease NF-κBp65 subunit level | [70] | |
Wu Zhu Yu | DSS-induced colon tissues | Down-regulate the increased phosphorylation levels of NF-κBp65 | [71] | |
Clove | TNBS-induced colon tissue | Down-regulate the expressions of NF-κBp65 | [72] | |
DSS-induced colon tissues | Reduce the expressions of p65-NF-κB | [73] | ||
RAW264.7 macrophages | Decrease the expressions of p65-NF-κB | [73] | ||
Zanthoxylum bungeanum | DSS-induced colon tissue | Inhibit NF-κBp65 phosphorylation levels | [74] | |
Galangin | DSS-induced colon tissue | Suppress protein expressions of p-NF-κB; Decrease the accumulation of nuclear NF-κBp65 | [75] | |
Detoxificating and purgative medicine | Parthenolide | DSS-induced colon tissue | Inhibit the phosphorylation of NF-κBp65 | [76] |
HCT116 cells | Block the activation of p65 | [77] | ||
Arctigenin | DSS-induced colonic tissues | Suppress phosphorylation of NF-κBp65 and p65 translocation | [78] | |
Andrographolide derivative AL-1 | TNBS-induced colon tissues | Aattenuate the expression levels of p-p65 | [79] | |
Andrographolide derivative CX-10 | DSS-induced colonic tissue | Reduce the expressions of NF-κB p65 | [80] | |
Brusatol | DSS-induced colon tissue | Attenuate the expression of NF-κBp65 | [81] | |
Brucea javanica oil | DSS-induced colon tissues | Suppress the NF-κB activation; Inhibit the phosphorylation of NF-κBp65 | [82] | |
Total flavonoids of Hedyotis diffusa Willd | RAW 264.7 cells | Reduce the phosphorylation of NF-κBp65 | [83] | |
Oldenlandia diffusa | DSS-induced colon tissues | Reduce the activation of NF-κBp65 | [84] | |
Qing Dai | RAW264.7 cells | Abolish NF‑κBp65 translocation to the nucleus | [86] | |
Indirubin | DSS-induced colon tissues | Reverse DSS-mediated up-regulation of p-NF-κBp65 | [87] | |
Dandelion | DSS-induced NCM460 cell | Decrease the phosphorylation of NF‑κBp65 | [88] | |
Portulaca oleracea L. | DSS-induced colon tissues | Reduce the protein expressions of NF-κBp65 | [89] | |
Rhubarb-type anthraquinones | RAW264.7 macrophages | Rhein reduce phosphor-NF-κBp65 levels | [91] | |
HT-29 cells | Emodin block NF-κBp65 nuclear translocation | [92] | ||
DSS-induced colitis tissues | Chrysophanol reduce the activation of NF-κBp65 | [93] | ||
Gallic acid | DSS-induced colon tissue | Inhibit the nuclear translocation of NF-κBp65 | [94] | |
RAW264.7 macrophage | Decrease the expression of NF-κBp65 | [94] | ||
Allicin | DSS-induced colonic mucosa | Prevent the inhibition of inducing nuclear translocation of NF-κBp65 | [95] | |
Cassia obtusifolia | DSS-induced colon tissues | Reduce the level of NF-κBp65 | [96] | |
Bergenin | RAW264.7 cells | Suppress the nuclear translocation and DNA-binding activity of NF-κBp65; Inhibit the acetylation of NF-κBp65, increase the association of NF-κBp65 and IκBα, and hinder the nuclear translocation of NF-κBp65 | [97] | |
Fagopyrum cymosum (Trev.) Meisn | Raw264.7 cells | Inhibit NF-κBp65 nuclear translocation | [98] | |
Chlorogenic acid | DSS-induced colon mucosa | Reduce the phosphorylation level of NF-κBp65 protein | [99] | |
Blood-activating medicine | Paeonol | CW-2 cells | Reduce NF-κB transactivation | [99] |
Liriodendrin | DSS-induced colon tissues | Suppress the activation of NF-κB pathways; Reduce in phosphorylation of NF-κB | [101] | |
RAW264.7 macrophages | Reduce the phosphorylation of NF-κB | [101] | ||
Shikonin | DSS-induced colon tissues | Reduce the expression of NF-κBp65 | [102] | |
Tetramethylpyrazine | OXZ-induced colitis mucosa | Reduce the rise in NF-κBp65 | [103] | |
Crocetin | TNBS-induced colonic mucosa | Down-regulate the NF-κB | [104] | |
Epicatechin | RAW264.7 cells | Inhibit the activation of NF-κB | [105] | |
Curcumin | Colonic mucosa | Modulate NF-κB activation | [110] | |
Qi-regulating medicine | Norisoboldine | DSS-induced colon tissues | Inhibit phosphorylation, nuclear translocation and DNA-binding activity of NF-κBp65 | [113] |
Citrus aurantium L. | TNBS-induced colon tissues | Inhibit the NF-κB pathway | [114] | |
RAW264.7 cells | Inhibit the protein expressions of NF-κB | [114] | ||
Tonifying medicine | Eclipta Prostrata | HT-29 cells | Reduce the nuclear translocation of NF-κB | [115] |
Astragalus polysaccharide | DSS-induced colonic tissues | Reduce NF-κB DNA phosphorylation activity | [116] | |
Astragaloside IV | CCD‑18Co cells | Inhibit the phosphorylation of NF‑κBp65 | [117] | |
Licochalcone A | DSS-induced colonic tissues | Reverse the increased expression of p65 NF-κB | [118] | |
Diammonium glycyrrhizinate | AA-induced colonic tissues | Suppress the positive percentage and density of NF-κBp65 | [119] | |
Vanillic acid | DSS-induced colon tissues | Suppress the activation of transcription NF-κBp65 | [120] | |
Paeoniflorin | TNBS-induced colon tissues | Inhibit the expressions of p-NF-κB | [121] | |
The fruit of Ziziphus jujuba Mill. | AOM/DSS-induced colon tissue | Attenuate the expression of proteins in the NF-κB | [122] | |
Oligonol | DSS-induced colon tissue | Decrease nuclear translocation of NF-κBp65 | [123] | |
Lentinus edodes β-glucans | RAW264.7 cells | Inhibit NF-κB activation | [124] | |
Mango extract | CCD-18Co cells | Reduce expression of NF-κB and pNF-κB protein | [125] | |
Astringent medicine | Muscovite | Iodoacetamide-induced colitis tissues | Decrease the activity of NF-κBp65 and reduce the p65 transferred into the nucleus | [126] |
Shan Zhu Yu | Human umbilical vein endothelial cells (HUVECs) | Attenuate NF-κB expression | [127] | |
Macrophages | Inhibit NF-κB activation | [129] | ||
Rubus coreanus | RAW264.7 macrophages | Attenuate the nuclear translocations of NF-κBp65 | [130] | |
RAW 264.7 cells | Reduce NF-κB activity | [131] | ||
Osthole | DSS-induced colonic tissue | Reduce the expression of NF-κBp65 | [132] | |
Tonifying Qi and activating blood category | Tou Nong San | TNBS-induced colon tissue | Reduce the activation of the NF-κBp65 | [134] |
Heat-clearing and drying dampness category | Shaoyao Decoction | AOM/DSS-induced colonic tissues | Suppress NF-κB activation | [135] |
Qingchang Huashi recipe | HT-29 cells | Reduce the activation of NF-κB | [137] | |
Gegenqinlian Decoction | TNBS-induced colon tissue | Inhibit the activation and translocation of NF-κBp65 | [138] | |
DSS-induced colonic tissues | Decrease the P-NF-κBp65 | [139] | ||
RAW 264.7 cells | Down-regulate the expression of P-NF-κBp65 | [139] | ||
Jianpi Qingchang decoction | DSS‑induced colon tissue | Inhibit the activation of the NF-κB | [140] | |
Modified pulsatilla decoction | OXZ-induced colon tissues | Suppress the activation of the NF-κB | [142] | |
Qing Hua Chang Yin | DSS‑induced colon tissue | Inhibit the expression of the nuclear translocation of NF‑κB | [143] | |
QingBai decoction | DSS‑induced colon tissue | Decrease the protein level of P-NF-κBp65 | [145] | |
Chang-An-Shuan | TNBS-induced colonic tissues | Down-regulate the expression levels of NF-κBp65 | [146] | |
Baishaoqiwu | TNBS-induced colon tissues | Inhibit expression of the NF-ĸBp65 genes | [147] | |
Xie-xin decoction | TNBS-induced colon tissues | Decrease expression of NF-ĸBp65 | [148] | |
Compound sophorae decoction | DSS‑induced colonic tissues | Reduce the level of phospho-NF-κBp65 | [149] | |
Huangkui Lianchang decoction | DSS-induced Colon Tissue | Decrease the NF-B levels | [150] | |
Bawei Xilei powder | UC patients | Decrease the expression of NF-κBp65 | [151] | |
Harmonizing cold and hot category | Ban-xia-xie-xin decoction | DSS-induced colorectums | Inhibition of NF-κBp65 activation | [152] |
Wu-mei-wan | DNCB-induced colonic tissue | Inhibit the NF-κBp65 activity | [153] | |
Warming yang and drying dampness category | Modified ZenWu decoction | DSS-induced colonic tissues | Attenuate the activation of NF-κB and suppress the expression of NF-κBp65 | [154] |
Ping weisan | DSS-induced colon tissues | Reduce phosphorylation of NF-κBp65 | [155] | |
RAW264.7cells | Reduce phosphorylation of NF-κBp65 | [155] | ||
Astringent category | Zhenrenyangzang decoction | TNBS-induced colon tissues | Reduce NF-κB mRNA expression | [156] |